Co-Diagnostics Common Stock Net 2017-2025 | CODX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Co-Diagnostics common stock net from 2017 to 2025. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Co-Diagnostics common stock net from 2017 to 2025. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$141.1B
CVS Health (CVS)	$79B
Elevance Health (ELV)	$61.8B
Cencora (COR)	$55.9B
DiDi Global (DIDIY)	$23.4B
Labcorp Holdings (LH)	$21.9B
Natera (NTRA)	$18.4B
BioMerieux (BMXMF)	$17.1B
EUROFINS SCIENT (ERFSF)	$15.1B
ICON (ICLR)	$13.4B
CochLear (CHEOY)	$13.2B
Solventum (SOLV)	$12.4B
Medpace Holdings (MEDP)	$11.9B
Revvity (RVTY)	$10.4B
Viatris (VTRS)	$10.3B
Sonic Healthcare (SKHHY)	$8.7B
Charles River Laboratories (CRL)	$8.2B
HealthEquity (HQY)	$7.9B
Avantor (AVTR)	$7.7B
Caris Life Sciences,�Inc (CAI)	$7.1B
Bausch + Lomb (BLCO)	$4.8B
Amplifon S.p.A (AMFPF)	$3.9B
BrightSpring Health Services (BTSG)	$3.5B
Sotera Health (SHC)	$3.2B
GeneDx Holdings (WGS)	$2.9B
Surgery Partners (SGRY)	$2.7B
Alignment Healthcare (ALHC)	$2.6B
Organon (OGN)	$2.5B
Concentras Parent (CON)	$2.5B
Progyny (PGNY)	$1.9B